Accelerate More Molecules To Clinic

Source: Catalent
molecules to clinic

The days of “low-hanging fruit” in the drug discovery era when new chemical entities were highly permeable and soluble are over. As the nature of the target molecule becomes increasingly challenging, the need is to move away from the current linear and siloed drug development approach. This infographic highlights a customized and multidisciplinary approach that can identify the most suitable drug delivery technology during early stage of drug development and reduce potential risks and contribute to overall time and cost savings.